← Back to ONCY

Oncolytics Biotech Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 14/05/2026Jun 2025Filed 12/08/2026Mar 2025Filed 14/05/2026
−$9.4−$9.2−$5.3−$4.7
−$0.08−$0.08−$0.06−$0.06
1201129185

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.